New GWAS for Parkinson's disease‼️🧬
👉63,555 cases, 17,700 proxy cases, 1,746,386 controls
👉134 risk loci (59 new)
For common diseases, increases in GWAS sample sizes keep offering significant knowledge gains!
Post-GWAS analyses also tend to be very informative
with (i) extensive fine-mapping and (ii) elegant efforts to integrate multi-omics/molQTL data for detection of effector genes (=potential drug targets)💊